A Phase I/IIa Trial Using CD19-Targeted Third-Generation CAR T Cells for Lymphoma and Leukemia - Concepedia

Concepedia

Publication | Closed Access

A Phase I/IIa Trial Using CD19-Targeted Third-Generation CAR T Cells for Lymphoma and Leukemia

250

Citations

24

References

2018

Year

Gunilla Enblad, Hannah Karlsson, Gustav Gammelgård, Jessica Wenthe, Tanja Lövgren, Rose‐Marie Amini, Kristina Wikström, Magnus Essand, Barbara Savoldo, Heléne Hallböök,

Clinical Cancer Research

Abstract

Third-generation CARs may be efficient in patients with advanced B-cell lymphoproliferative malignancy with only modest toxicity. Immune profiling pre- and posttreatment can be used to find response biomarkers.

References

	Year	Citations

Page 1